Arazlo
Active Ingredient(s): TazaroteneFDA Approved: * December 18, 2019
Pharm Company: * DOW PHARM
Category: Skin Care
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Arazlo Overview
Tazarotene (marketed as Tazorac, Avage, Zorac, and Fabior) is a third-generation prescription topical retinoid sold as a cream, gel, or foam. Tazarotene is a member of the acetylenic class of retinoids. This medication is approved for treatment of psoriasis, acne, and sun damaged skin (photodamage). It is commonly sold in two concentrations: 0.05% and 0.1%. Contents 1 Medical uses 1.1 Available forms 2 Side effects 3 Synthesis 4 Notes Medical uses Tazarotene is most commonly used t...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tazarotene
Recent Arazlo Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Tazarotene
- Aerosol, Foam: 0.1%
- Cream: 0.05%, 0.1%, 0.10%, 1%
- Foam: 0.1%
- Gel: 0.05%, 0.1%, 0.10%
- Lotion: 0.045%
NDC Database Records for Arazlo: (1 result)
Sorted by National Drug Code- 0187-2098 Arazlo .45 mg/g Topical Lotion by Bausch Health Us LLC
Other drugs which contain Tazarotene or a similar ingredient: (5 results)
- FABIOR Tazarotene
- TAZAROTENE
- TAZORAC Tazarotene1 discussion
- DUOBRII Halobetasol Propionate + Tazarotene
- HALOBETASOL PROPIONATE + TAZAROTENE